Immuno-oncology Market Trends and Opportunities And Forecast Report | Amgen, AstraZeneca, Bristol-Myers Squibb, Dendreon Pharmaceuticals, Gilead Sciences, Medac Pharma, Merck & Co., Merck KGaA, Novartis, Pfizer, Sanofi

Immuno-oncology Development Trends and Opportunities

Immuno-oncology (IO) is the treatment of cancer with therapies that stimulate or suppress the body's own immune system. Several distinct modalities of IO therapy exist, including bispecific T-cell engaging monoclonal antibodies, cellular immunotherapy and adoptive cellular therapy, cancer vaccines, checkpoint modulating monoclonal antibodies, and oncolytic viruses.

Companies Covered in this Report are:

Amgen
AstraZeneca
Bristol-Myers Squibb
Dendreon Pharmaceuticals
F. Hoffmann-La Roche
Gilead Sciences
Medac Pharma
Merck & Co.
Merck KGaA
Northwest Biotherapeutics
Novartis
Pfizer
Regeneron Pharmaceuticals
Sanofi
Shanghai Sunway Biotech
Shire Pharmaceuticals

Get Sample Copy of "Immuno-oncology Market" at:
https://www.premiummarketinsights.com/sample/GD00007066

This report provides an overview of current clinical development trends for IO within the 8MM (France, Germany, Italy, Spain, UK, US, Japan, China), including a history of recent approvals, indications currently being explored for IO agents of all modalities, targets being selected for IO therapies, and combination strategies being investigated for approved IO agents. In addition, the report provides disease overviews, epidemiology, current recommended treatment regimens and IO approvals, and IO clinical trial trends for 17 indications which Publisher has identified as representing the largest commercial opportunities for IO agents. Clinical trial trends analyze ongoing trials by sponsor type and modality, as well as ongoing combination trials for approved IO therapies.

Scope

This report combines primary research from a cross-specialty panel of oncology experts with in-house analyst expertise to provide an assessment of the development landscape. Components of the slide deck include primary and secondary research-
-Quotes from 13 US-, 5EU-, and Japan-based key opinion leaders
-Summary of IO product definitions and classifications
-Overview of development opportunities for IO agents across indications, including emerging indications and clinical targets, and novel combination strategies
-Outline of 17 key indications for IO agents, including current EU and US guideline recommendations, IO's current place in the treatment algorithm, and a review of ongoing clinical trials
-Call-outs of key information and details
-Insight from Publisher's specialist oncology analysts.

Reasons to buy

-Develop business strategies by understanding the trends shaping and driving IO in the 8MM.
-Drive revenues by understanding the key trends, innovative combination strategies and indications likely to impact the IO market in the future.
-Design your development strategy through a review of potential novel targets or combinations across indications.
-Organize your sales and marketing efforts by understanding IO combination approaches across indications that present maximum opportunities for consolidations, investments, and strategic partnerships.
-Develop strategies by understanding expert perceptions of unmet needs in key indications in oncology, and the potential for IO agents to meet those needs.

To Purchase This report details at:
https://www.premiummarketinsights.com/buy/GD00007066

Table of Contents:
1. Preface 2
2. Executive Summary 12
3. Introduction 17
4. Development Opportunities for IO Agents 23
5. Acute Lymphoblastic Leukemia (ALL) 78
6. Bladder Cancer 89
8. Chronic Lymphocytic Leukemia (CLL) 108
9. Colorectal Cancer 116
10. Gastric and Gastroesophageal Cancer (GA/GEJAC) 126
11. Glioblastoma 136
12. Head and Neck Cancer 144
13. Hepatocellular Carcinoma (HCC) 154
14. Melanoma 164
15. Multiple Myeloma 175
16. Non-Hodgkin Lymphoma (NHL) 183
17. Non-Small Cell Lung Cancer (NSCLC) 193
18. Ovarian Cancer 204
19. Pancreatic Cancer 212
20. Prostate Cancer 220
21. Renal Cell Carcinoma (RCC) 230
22. Appendix 240

About Premium Market Insights:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

Contact Us:
Contact Person: Sameer Joshi
Email: [email protected]

Posted by Rajat Sahni on Friday January 04 2019, 7:12 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0